David Yu Selected Research

David Yu Research Topics

Disease

7	Ankylosing Spondylitis 01/2021 - 06/2007
4	COVID-19 11/2023 - 01/2020
3	Neoplasms (Cancer) 03/2024 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 10/2022
3	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 12/2023 - 04/2023
3	Arthritis (Polyarthritis) 10/2019 - 06/2011
2	Blister (Bulla) 12/2023 - 04/2023
2	Infections 11/2023 - 01/2022
2	Pneumonia (Pneumonitis) 11/2023 - 10/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2022 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2008
2	Low Back Pain (Lumbago) 05/2011 - 11/2009
1	Virus Diseases (Viral Diseases) 11/2023
1	Sepsis (Septicemia) 11/2023
1	Lipodystrophy 04/2023
1	Rectal Neoplasms (Rectal Cancer) 03/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2023
1	COVID-19 related pediatric multisystem inflammatory disease 10/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2022
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2019
1	Hemorrhage 10/2019
1	Dyspnea (Shortness of Breath) 10/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Axial Spondyloarthritis 12/2017
1	Ankylosis 12/2017
1	Spondylarthropathies 12/2017
1	Heart Failure 02/2013
1	Immune System Diseases (Immune Disorders) 06/2011
1	Rheumatoid Arthritis 09/2010
1	Spondylarthritis (Spinal Arthritis) 11/2009
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Reactive Arthritis (Reiter Disease) 02/2003

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2009
3	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 12/2023 - 10/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 01/2008
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2011 - 02/2003
2	AutoantigensIBA 12/2023 - 10/2022
2	Immunoglobulin D (IgD)IBA 12/2023 - 04/2023
2	AntigensIBA 04/2023 - 10/2022
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2019 - 10/2019
2	EnzymesIBA 01/2019 - 09/2010
2	lei gong tengIBA 06/2011 - 09/2010
1	AutoantibodiesIBA 11/2023
1	Interferon Type IIBA 11/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2023
1	ProcalcitoninIBA 11/2023
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Perilipin-1IBA 04/2023
1	Peptides (Polypeptides)IBA 04/2023
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	SteroidsIBA 10/2019
1	uridine triacetateIBA 01/2019
1	AntidotesIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 12/2017
1	Small Molecule LibrariesIBA 06/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2011
1	ProteomeIBA 01/2008
1	Infliximab (Remicade)FDA Link 06/2007

Therapy/Procedure

6	Therapeutics 03/2024 - 06/2011
3	Radiotherapy 03/2024 - 01/2020
2	Critical Care (Surgical Intensive Care) 11/2023 - 01/2022
1	Neoadjuvant Therapy 03/2023
1	Ileostomy 03/2023
1	Extracorporeal Membrane Oxygenation 01/2022
1	Combined Modality Therapy 01/2020
1	Immunotherapy 01/2019
1	Drug Substitution 12/2017
1	Biological Therapy 12/2017
1	Drug Therapy (Chemotherapy) 01/2008